Delhi High Court Revisits Pharmaceutical Patent Law in Intra Cellular Therapies Case
In a significant ruling, the Delhi High Court addressed key issues in pharmaceutical patent law, particularly concerning coverage disclosure and therapeutic efficacy under Section 3(d) in the Intra Cellular Therapies v. Controller of Patents case.